Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yonghua Chen has a total of 145 co-authors. Here are the top co-authors by number of shared publications:

  • Rui Wang

    Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China

    8 shared publications
  • Chunlu Tan

    Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China

    7 shared publications
  • Xubao Liu

    Division of Pancreatic Surgery, Department of General Surgery, West China Hospital of Sichuan University , Chengdu, Sichuan, CN 610041

    7 shared publications
  • Xubao Liu

    West China Hospital of Sichuan University, Chengdu, China

    7 shared publications
  • Chun-Lu Tan

    Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China

    5 shared publications
  • Xing Wang

    Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan CN 610041, China

    5 shared publications

Latest Publications

  • Pancreatic Fat and the Risk of Future Dysglycemia: A Systematic Review and Meta-analysis

    by Jie Yang, Xuan Zhang, Lihong Luo, Zhenjiang Zheng, Chunlu Tan, Xubao Liu, Yonghua Chen

    Context: Pancreatic fat has emerged as a metabolically relevant ectopic fat depot, but its longitudinal association with future dysglycemic outcomes remains incompletely defined. Objective: To evaluate the longitudinal association of pancreatic fat with incident type 2 diabetes (T2D) and glycemic progression, with exploratory narrative synthesis of evidence in lean populations. Data Sources: PubMed, Embase, Web of Science, and the Cochrane Library were searched from inception to March 1, 2026. Study Selection: Longitudinal observational studies assessing pancreatic fat at baseline and reporting subsequent incident T2D, glycemic progression, or both were included. Data Extraction: Two reviewers independently screened studies and extracted data. Methodological quality was assessed using the Newcastle-Ottawa Scale. Data Synthesis: Ten studies were included. In the primary binary meta-analysis (5 studies), higher pancreatic fat burden was associated with incident T2D (pooled effect estimate, 2.56; 95% CI, 1.27-5.14; I2 = 93.3%). Exclusion of 1 influential ultrasound-based study attenuated heterogeneity while preserving the association (pooled effect estimate, 1.45; 95% CI, 1.23-1.73; I2 = 10.2%). A separate continuous analysis (3 studies) also supported an association with incident T2D (1.17; 95% CI, 1.04-1.32; I2 = 79.2%), although exposure scales were not directly comparable. Pancreatic fat was also associated with glycemic progression (2 studies; 1.96; 95% CI, 1.10-3.48; I2 = 73.2%). Exploratory lean-population evidence was limited to 2 analytical contexts, synthesized narratively, and directionally consistent with the overall findings. Conclusions: Pancreatic fat was associated with adverse future glycemic outcomes across multiple analytical contexts. These findings support pancreatic fat as a potentially meaningful imaging-derived marker of future dysglycemia, while suggesting that heterogeneity is partly explained by differences in exposure ascertainment.


  • Open Access

    Self‐Reported Plastic‐Related Occupational Scenarios and Perceived Support Priorities Among Operating‐Room Nursing Staff: A Multicentre Cross‐Sectional Survey

    by Jie Yang, Panyu Chen, Zhihui Huang, Lin Yang, Qian Feng, Xiaoli Zhong, Qinghua Zhang, Junhong Zhou, Jun Cheng, Meng Shi, et al.

    Aim(s): To examine work‐context associations with self‐reported plastic‐related occupational scenario burden and perceived support priorities among operating‐room nursing staff. Background: Operating rooms rely heavily on plastic‐containing disposable materials and smoke‐generating workflows, but nursing‐management evidence on how staff report these occupational scenarios remains limited. Method(s): This exploratory multicentre cross‐sectional survey included 448 eligible nursing personnel from nine recruitment groups in China (eight hospital‐based; one visiting‐nurse training cohort); 415 frontline staff formed the analytic population. The principal outcome was a 0–100 formative occupational scenario‐burden index. Adjusted linear regression included recruitment‐group fixed effects, with alternative index definitions and binary distribution‐based outcomes examined as sensitivity analyses. Results: Among 415 frontline operating‐room nursing staff, the mean occupational scenario‐burden score was 50.7 (SD 12.4); 408 participants had complete data for the principal regression. Night‐shift status was associated with a 3.86‐point higher score (HC3 95% CI 0.96–6.76), and this association remained positive across the principal sensitivity analyses. Orthopaedic involvement was associated with a 4.93‐point higher score in the original index, although the estimate attenuated after specialty‐specific content was removed. The most frequently endorsed support priorities were rest‐area water infrastructure (69.9%), meal‐container reform (63.6%) and ventilation/smoke‐management optimisation (63.4%). Conclusion(s): Night‐shift work was associated with higher self‐reported occupational scenario burden, with positive point estimates across the principal sensitivity analyses, whereas the specialty‐related association was more sensitive to index composition. These findings identify organisational priorities for review and provide a basis for prospective studies integrating validated scenario measures with objective exposure assessment. Implications for Nursing Management: Staff‐endorsed priorities provide a practical agenda for nurse managers to review workflows, smoke‐control practices, procurement, rest‐area infrastructure and night‐shift support and to select priorities for prospective evaluation.

  • Open Access

    Efficacy of the SUPERvised PREhabilitation with Personalised, Aerobic training, Respiratory muscle training and EDucation (SUPER-PREPARED) multi-model in patients with abdominal surgery: protocol for a single-blind, randomised controlled trial

    by Jiao Wang, Yuekong Hu, Xiaojie Ju, Yonghong Yang, Hongyu Chen, Yonghua Chen

    Introduction: Globally, millions of abdominal surgeries are performed annually, placing a substantial burden on public health systems worldwide. Postoperative pulmonary complications (PPCs) are common negative consequences after major abdominal surgery that can worsen recovery outcomes. Although the effect of prehabilitation has been frequently investigated in this population, the feasibility and efficacy of delivering a supervised, intensive exercise programme within a limited preoperative period remain underexplored. This randomised controlled trial (RCT) aims to evaluate the effectiveness of the SUPERvised PREhabilitation with Personalised, Aerobic training, Respiratory muscle training and patient EDucation (SUPER-PREPARED) multi-model to reduce the incidence of PPCs among the population undergoing abdominal surgery. Methods and analysis: The SUPER-PREPARED trial will be a single-centre, prospective, two-arm RCT. A total of 120 participants will be recruited and randomly allocated to either the SUPER-PREPARED group or the usual care group. The primary outcome is the incidence of PPCs, assessed at specific time points (1 day before discharge and 1 month, 6 months and 1 year after surgery). The secondary outcomes include patient-centred measures (functional capacity, quality of life), clinical measures (respiratory muscle function, pulmonary function) and postoperative recovery metrics (postoperative intestinal ventilation timing, length of intensive care unit (ICU) stay, length of postoperative hospital stay, postoperative hospitalisation expenses and readmission rate). The detailed criteria defining PPCs and the schedule of the study are displayed in tables. Data analysis will be independently conducted by two experienced clinicians via the per-protocol analysis. Ethics and dissemination: This study will be conducted in strict accordance with the Declaration of Helsinki (2024). The protocol was approved by the Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (2024 nianshen No. 2049). The final results will be disseminated by peer-reviewed journals and presentations at academic conferences. Trial registration number: ChiCTR2500102615.


  • Open Access

    Neuroimmune Interactions in Pancreatic Cancer

    by Jun Cheng, Rui Wang, Yonghua Chen

    Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive primary malignancy, and recent technological advances in surgery have opened up more possibilities for surgical treatment. Emerging evidence highlights the critical roles of diverse immune and neural components in driving the aggressive behavior of PDAC. Recent studies have demonstrated that neural invasion, neural plasticity, and altered autonomic innervation contribute to pancreatic neuropathy in PDAC patients, while also elucidating the functional architecture of nerves innervating pancreatic draining lymph nodes. Research into the pathogenesis and therapeutic strategies for PDAC, particularly from the perspective of neuroimmune network interactions, represents a cutting-edge area of investigation. This review focuses on neuroimmune interactions, emphasizing the current understanding and future challenges in deciphering the reciprocal relationship between the nervous and immune systems in PDAC. Despite significant progress, key challenges remain, including the precise molecular mechanisms underlying neuroimmune crosstalk, the functional heterogeneity of neural and immune cell populations, and the development of targeted therapies that exploit these interactions. Understanding the molecular events governing pancreatic neuroimmune signaling axes will not only advance our knowledge of PDAC pathophysiology but also provide novel therapeutic targets. Translational efforts to bridge these findings into clinical applications, such as immunomodulatory therapies and neural-targeted interventions, hold promise for improving patient outcomes. This review underscores the need for further research to address unresolved questions and translate these insights into effective therapeutic strategies for PDAC.


  • Open Access

    Neuroimmune Interactions in Pancreatic Cancer

    by Jun Cheng, Rui Wang, Yonghua Chen

    Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive primary malignancy, and recent technological advances in surgery have opened up more possibilities for surgical treatment. Novel data show that diverse immune and neural components play essential roles in the aggressive behavior of PDAC. Recent studies have shown that neural invasion, neural plasticity, and altered innervation of autonomic nerve fibers are involved in pancreatic neuropathy in PDAC patients and have clarified the functional structure of the nerves innervating pancreatic draining lymph nodes. Notably, research on the pathogenesis and therapeutic options for treating PDAC from the viewpoint of interactions of the neuroimmune network is at the cutting edge. In this review, we present a special focus on neuroimmune interactions that highlight the current state of knowledge and future challenges concerning the reciprocal relationship between the immune system and nervous system in PDAC. Understanding the molecular events governing the pancreatic neuroimmune signaling axes will enhance our knowledge of physiology and may provide novel therapeutic targets for treating PDAC.

  • YAP promotes fibrosis by regulating macrophage to myofibroblast transdifferentiation and M2 polarization in chronic pancreatitis

    by Qingquan Tan, Chengzhi Xiang, Haoqi Zhang, Yuan Yuan, Songlin Gong, Zhenjiang Zheng, Xing Wang, Xubao Liu, Yonghua Chen, Chunlu Tan


  • Open Access

    Remnant Pancreas Volume Affects New-Onset Impaired Glucose Homeostasis Secondary to Pancreatic Cancer

    by Jie Yang, Chunlu Tan, Ya Liu, Zhenjiang Zheng, Xubao Liu, Yonghua Chen

    Background: New-onset diabetes (NOD) has been identified as a high-risk factor for the early detection of pancreatic ductal adenocarcinoma (PDAC). The role of tumor volume and remnant pancreas volume (RPV) in the progression from normal to NOD in PDAC patients is not fully illustrated yet. Methods: In this cross-sectional study, glycemic metabolism traits of 95 PDAC patients before pancreatic surgery were described and compared with chronic pancreatitis and type 2 diabetes mellitus patients based on the oral glucose tolerance test. The remnant RPV and tumor volume, calculated by three-dimensional reconstruction of radiological images, were included in the ordinal logistic regression models. Results: The prevalence of NOD was high among PDAC patients (38.9%). However, normal glucose tolerance (NGT) or prediabetes mellitus status were present as more than half (24/44) of advanced tumor stage patients. Indexes reflecting beta-cell function but not insulin sensitivity gradually worsened from NGT to NOD patients (all p < 0.05). The remnant pancreas volume (RPV) was identified as a potential protective factor for diabetes secondary to PDAC (odds ratio 0.95, 95% CI [0.92, 0.97], p < 0.001). Conclusions: Reduced RPV causing beta-cell dysfunction might be one of the mechanisms of NOD secondary to PDAC. Subjects with sufficient pancreas volume could not be detected earlier when regarding patients with NOD as the population at risk for PDAC.


  • Top Cited Papers
    Open Access

    Impact of an AI-based laparoscopic cholecystectomy coaching program on the surgical performance: a randomized controlled trial

    by Shangdi Wu, Ming Mm Tang, Jie Bs Liu, Dian Qin, Yuxian Bs Wang, Siwei Zhai, Enxu Bi, Yichuan Li, Chunrong Wang, Yong Xiong, et al.

    Background: Laparoscopic cholecystectomy (LC) is the gold standard for treating symptomatic gallstones but carries inherent risks like bile duct injury. While the critical view of safety (CVS) is advocated to mitigate bile duct injury, its real-world adoption is limited. Additionally, significant variations in surgeon performance impede procedural standardization, highlighting the need for a feasible, innovative, and effective training approach. The aim of this study is to develop an artificial intelligence (AI)-assisted coaching program for LC to enhance surgical education and improve surgeon’s performance. Materials and methods: The authors conducted a multicenter, randomized controlled trial from May 2022 to August 2023 to assess the impact of an AI-based coaching program, surgical coaching program, on novice performing LC. Surgeons and patients meeting specific inclusion criteria were randomly assigned to either a coaching group with AI-enhanced feedback or a self-learning group. The primary outcome was assessed using the Laparoscopic Cholecystectomy Rating Form, with secondary outcomes including surgical safety, efficiency, and adverse events. Statistical analyses were performed using SPSS, with significance set at a P-value less than 0.05. Results: Between May 2022 and August 2023, 22 surgeons were initially enrolled from 10 hospitals, with 18 completing the study. No demographic differences were noted between coaching and self-learning groups. In terms of surgical performance (Laparoscopic Cholecystectomy Rating Form scores), the coaching group showed significant improvement over time (31 to 40, P=0.008), outperforming the self-learning group by study end (40 vs 38, P=0.032). Significant improvements in CVS achievement were also noted in the coaching group (11% to 78%, P=0.021). Overall, the coaching program was well-received, outpacing traditional educational methods in both understanding and execution of CVS and participants in the intervention group expressed strong satisfaction with the program. Conclusions: The AI-assisted surgical coaching program effectively improved surgical performance and safety for novice surgeons in LC procedures. The model holds significant promise for advancing surgical education.